ERBB2 and gastric cancer: To assess this possibility, we first validated our results using two cancer cell models, 23132/87 (gastric cancer cell line) and SKBR3 (HER2 breast cancer) with very low or undetectable expression of GSDMB (Supplementary Fig. 1B).